Key facts
- This page summarizes Stephen L. Hurst's Form 3 filing for Mind Medicine (MindMed) Inc. (MNMD).
- 0 reported transactions and 2 derivative rows are listed below.
- Accepted by SEC: 10 Jan 2022, 20:31.
Stephen L. Hurst - 01 Jan 2022 Form 3 Insider Report for Mind Medicine (MindMed) Inc. (MNMD)
- Reporting relationship
- Director
- Issuer ticker
- MNMD
- Reported as of
- 01 Jan 2022
- Net transaction value
- $0
- SEC form
- 3
- Accepted by SEC
- 10 Jan 2022, 20:31:18 UTC
- Next SEC filing
- 25 Mar 2022
- Source filing
- View source filing
- Reporting owner signature
- /s/ Robert Barrow, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Stephen L. Hurst filed Form 3 for Mind Medicine (MindMed) Inc. (MNMD) on 10 Jan 2022.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Official SEC source
View source filing
Ownership activity is grounded in SEC Form 3 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
MNMD
holding
Subordinate Voting Shares
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 100
- Date
- 01 Jan 2022
- Ownership
- Direct
MNMD
holding
Subordinate Voting Shares
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 39,000,000
- Date
- 01 Jan 2022
- Ownership
- By Savant Addiction Medicine, LLC
- Footnotes
- F1
MNMD
holding
Subordinate Voting Shares
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 1,722,678
- Date
- 01 Jan 2022
- Ownership
- By Sunray Asset Management
- Footnotes
- F2
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
MNMD
holding
Derivative
Stock Option (Right to Buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 01 Jan 2022
- Ownership
- Direct
- Underlying class
- Subordinate Voting Shares
- Underlying amount
- 26,285
- Exercise price
- $2.91
- Footnotes
- F3, F4
MNMD
holding
Derivative
Directors' Deferred Share Units
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 01 Jan 2022
- Ownership
- Direct
- Underlying class
- Subordinate Voting Shares
- Underlying amount
- 22,375
- Exercise price
- Footnotes
- F5
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 5 footnotes
Footnote F1
These shares are owned by Savant Addiction Medicine, LLC ("Savant Addiction"). The Reporting Person is the managing member of Savant Addiction. The Reporting Person disclaims beneficial ownership of the shares owned by Savant Addiction except to the extent of his pecuniary interest therein.
Footnote F2
These shares are owned by Sunray Asset Management, Inc. ("Sunray"). The Reporting Person is the Managing Director of Sunray. The Reporting Person disclaims beneficial ownership of the shares owned by Sunray except to the extent of his pecuniary interest therein.
Footnote F3
The shares underlying the option shall vest and become exercisable in 12 equal monthly installments beginning on March 15, 2021, subject to the Reporting Person providing continuous service to the Issuer on each such date.
Footnote F4
The option grant has an exercise price of $3.70 Canadian Dollars. This represents the exercise price in United States Dollars.
Footnote F5
Represents Directors' Deferred Share Units ("DDSUs") granted pursuant to the Issuer's Directors' Deferred Share Unit Plan (the "Plan"), effective as of April 16, 2021. The DDSUs vest in equal monthly installments over 12 months beginning on March 27, 2021. The DDSUs acquired are to be settled in cash upon the termination of the Reporting Persons' directorship (with each DDSU representing the right to receive the cash equivalent of the fair market value of one Subordinate Voting Share). Pursuant to the Plan, the fair market value of a Subordinate Voting Share is equal to the volume weighted average trading price of a Subordinate Voting Share on the NEO exchange for the five business days immediately preceding the DDSUs vesting date. The DDSUs granted will expire no later than 90 days after the Reporting Person's termination date or such other reasonable time as may be determined by the Administrators (as defined in the Plan).
SEC remarks
Exhibit List - Exhibit 24- Power of Attorney